Pharmaceutical
Brains Bioceutical To List On NASDAQ Via SPAC At US$750m Valuation
Brains Bioceutical Corp. has announced plans to list on Nasdaq, in what would be the first US public-market debut for a UK-based cannabinoid pharma manufacturer since GW Pharmaceuticals was acquired by Jazz in 2021.